Mr. Blech is a renowned biotechnology entrepreneur and investor, who, over the past 35 years, has founded and served on the board of companies which have produced major advances in a broad array of diseases, including the diagnosis of chlamydia, herpes, syphilis and HIV, and the treatment of cystic fibrosis, sexual dysfunction, multiple myeloma and many forms of cancer and hematological disease. Mr. Blech’s current roles include Founder and Director of Cerecor, Inc., a CNS company, Director of ContraFect Corporation, an infectious disease company, Director of Medgenics, Inc., a biotechnology company, Vice Chairman of Edge Therapeutics, Inc., a company that treats life-threatening neurological conditions and Vice Chairman of InspireMD, a stent company. He is Vice Chairman of Centrexion Corporation, a company which is developing new modalities of pain control, Vice Chairman of Regenovation, Inc., a company developing new ways to regenerate human tissue, Vice Chairman of X4 Pharmaceuticals, a cancer immunology company, Vice Chairman of Sapience Therapeutics, an oncology company and Vice Chairman of Aridis Pharmaceuticals, a company with a product to treat pneumonia. He also serves as Vice Chairman of WaveGuide Corporation, a company developing the world’s smallest NMR machine.